<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="139548">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01896882</url>
  </required_header>
  <id_info>
    <org_study_id>UFRGS and HCPA - 120109</org_study_id>
    <nct_id>NCT01896882</nct_id>
  </id_info>
  <brief_title>Dietary Sodium Restriction in Hemodialysis Patients</brief_title>
  <official_title>Effects of Dietary Sodium Restriction in Hemodialysis Patients: Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <authority>Brazil: National Committee of Ethics in Research</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Excess dietary sodium can lead to poor outcomes, such as hypertension, edema and increased
      risk for cardiovascular diseases. These complications are associated with end stage renal
      disease (ESRD) progression and mortality in renal patients. This study aims to evaluate the
      effects of nutritional counseling restricting dietary sodium and its relation to clinical
      and diet factors, nutritional knowledge and quality of life in hemodialysis patients.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Sodium intake</measure>
    <time_frame>Baseline, 30, 90, 180 and 360 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Sodium intake will be evaluated by food record and a food frequency questionnaire.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Baseline, 180 and 360 days.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Quality of life will be evaluated by the Brazilian Portuguese version of the Kidney Disease and Quality-of-Life Short-Form (KDQOL-SF) questionnaire.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Interdialytic weight gain</measure>
    <time_frame>Baseline, 30, 90, 180 and 360 days.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Will be considered the amount of weight gain between 2 dialysis sessions.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">112</enrollment>
  <condition>Hemodialysis Patients</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nutritional education on sodium restriction diet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sodium restriction</intervention_name>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical stable patients on dialysis for at least 3 months, over 18 years old, of
             both sexes, who agree to participate in the study.

        Exclusion Criteria:

          -  Patients with low cognitive ability, psychiatric disorders, with acute or infectious
             disease.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gabriela Corrêa Souza, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Clínicas de Porto Alegre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital de Clínicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90035003</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <lastchanged_date>July 8, 2013</lastchanged_date>
  <firstreceived_date>July 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diet, Sodium-Restricted</keyword>
  <keyword>Food and Nutrition Education</keyword>
  <keyword>Renal Dialyisis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
